Asston Pharma Board Meeting on Sep 4 to Appoint Auditor, Hike Director Pay

Asston Pharmaceuticals Ltd has announced a Board of Directors meeting scheduled for September 4, 2026. The primary agenda items include the appointment of M/s Panchal S K & Associates as the new Statutory Auditor, consideration of retiring directors, and approval for increased remuneration for the Managing Director, Whole Time Director & CEO, and a Non-Executive Director. The meeting will also discuss the date and draft notice for the company's 7th Annual General Meeting.